Advertisement
Home 2018 May

Monthly Archives: May 2018

For children and younger adults with asthma

Asthma Mortality Inversely Tied to Deprivation in English Young

0
For those aged 5 to 44 years, positive link for deprivation with asthma prevalence, admissions
Hyoscyamine can prevent pacemaker placement in a patient with symptoms caused by a slow ventricular response during atrial fibrillation

Hyoscyamine Helps in A-Fib With Slow Ventricular Response

0
Successful response in patient with comorbidities who was a poor candidate for pacemaker placement
Among singleton pregnancies

Assisted Reproduction May Up Risk of Placental Anomalies

0
Risk of placenta previa, placental abruption up in ART vs. spontaneously conceived singleton pregnancies
An algorithm can be used to model and print a three-dimensional prosthesis of a human nose

Novel Algorithm Can Help Create 3-D Human Nose Prosthesis

0
High overall similarity between 3-D models and photographs of volunteers' noses
Use of systematic review methodology is associated with reduced likelihood of screening for rare diseases using the newborn blood spot test being recommended

Use of Systematic Reviews Affects Newborn Screening Policy

0
Reduces probability that screening for rare disease in newborn blood spot test will be recommended
The U.S. Food and Drug Administration has expanded its approval of the multiple sclerosis drug Gilenya (fingolimod) to include children aged 10 and older.

FDA Expands Use of MS Drug to Include Children

0
Gilenya is the first multiple sclerosis drug approved for children
Four lung cancer risk models perform best in selecting ever-smokers for screening

Risk Models Help Select Ever Smokers for Lung CA Screening

0
Four models were well-calibrated and had higher AUCs than five that overestimated risk
Receipt of opioid-related payments from industry in 2014 was associated with increased opioid prescribing in 2015

Opioid-Related Payments Linked to Increase in Opioid Rx

0
Receipt of any opioid-related payment from industry in 2014 tied to increase in opioid claims in 2015
Electroconvulsive therapy may be effective and cost-effective for U.S. patients with treatment-resistant depression

ECT Effective for Treatment-Resistant Depression

0
Third-line electroconvulsive therapy also cost-effective in base case, and in a range of sensitivity analyses

American Psychiatric Association, May 5-9

0
The 170th American Psychiatric Association Annual Meeting The annual meeting of the American Psychiatric Association was held from May 5 to 9 in...